Centre for Biomarker Research in Medicine. COMET Competence Centre for Excellent Technologies
|
|
|
- Ambrose Higgins
- 8 years ago
- Views:
Transcription
1 Centre for Biomarker Research in Medicine COMET Competence Centre for Excellent Technologies
2 Why Biomarker Research? early diagnosis, often before manifestation identification of at-risk patients for new cost-effective prevention concepts personalised therapy and therapy monitoring new diagnostic tests with high precision, fast analysis and low costs patient biobanking/analysis result sample basic research biomarkers targets for therapy 2
3 Vision Medical Vision CBmed aims to provide clinicians with easy to use, targeted, minimally invasive biomarkers for better diagnosis, therapy and monitoring of their patients Scientific Vision CBmed aims to combine different "-omics" technologies and advanced bioinformatics analyses for the fast identification of novel biomarkers but also to validate existing candidate biomarkers. Economic Vision CBmed aims to provide the necessary infrastructure for successful biomarker research and their translation into marketable products. 3
4 Aim & Objectives The overall aim of CBmed is to develop, validate and translate medical biomarkers for clinical practice. In cooperation with academic and industry partners the CBmed will be able to meet the following objectives: Take systematic biomarker research to the next level Build a strong network of research and industry partners Strategic planning based on industry and science Work on an international level Support gender aspects in research and management Efficient management 4
5 Cooperative Biomarker Research The biomarker research strategy at CBmed aims to establish longterm strategic partnerships with companies: access to the largest European Biobank Graz (>5 M samples) access to various clinical institutes and medical disciplines as well as biomarker research competence access to a broad national and European network of biomarker research (eg. BBMRI) access to specific clinical cohorts (clinical data, function tests, blood, serum, DNA, tissue) This cooperation offers a unique opportunity for industrial business development. 5
6 Scientific Programme 6
7 Industry Partners CBmed partners funded by K1 center non K-area 9.3 mio. 8.7 mio. additional commitment 3.8 Mio. Omnignostica total: 21.8 mio. 7
8 Shareholders Lead Partner 8
9 Scientific Partners Scientific partners: Biobanking and Biomolecular Resources Research Infrastructure- BBMRI (Frankreich) Austrian Breast & Colorectal Cancer Study Group- ABCSG (Ö) Ludwig Boltzmann Institut für experimentelle und klinische Traumatologie (Ö) Central European Society for Anticancer Drug Research- CESAR (Ö) Univ. Innsbruck (Ö) Know-Center (Ö) Secure Business Austria- SBA (Ö) Max-Planck-Institut für Molekulare Genetik (DE) Dahlem Center for Genome Research and Systems Biology (DE) Univ. München (DE) Univ. Jena (DE) Univ. of Queensland (Australien) Univ. of Iceland (Island) Univ. of Miami (USA) Univ. of Zagreb (Kroatien) Univ. of Uppsala (Schweden) Univ. of Toronto (Kanada) Associated scientific partners: National Institute of Health and Medical Research- INSERM (Frankreich) National Centre for Genomic Analysis- CNAG (Spanien) Deutsches Rheuma-Forschungszentrum Berlin- DRFZ (DE) Hebrew University Medical Centers (Israel) Freie Universität Berlin (DE) Univ. of Coventry (UK) Univ. of Sheffield (UK) 9
10 Organisational Structure General Assembly board of shareholders CEO - F Area 1 manager Area 2 manager CEO - S Area 3 manager Management Team (Project/Area Management, Office Management, Finance & Controlling, IPR, HR, Marketing, IT) International Ethical Advisory Board national and international ethics experts International Strategy Advisory Board International experts from industry and science Consortium Board Scientific and company partners, funding body, CEOs Area 1 Data & Technologies Projects Project Managers Area 2 Cancer Projects Project Managers Area 3 Metabolism & Inflammation Projects Project Managers 10
11 Timeline st half year nd half year 2015 M1 Initiation, Partner acquisition Application Submission: M2 Detailed planning Preparation for hearing FFG Hearing: Jury Decision: M3 Partner negotiations, Organisational structure CBmed Start CBmed:
12 CONTACTS Univ.-Prof. Dr.med. Thomas Pieber Dr. Selma Mautner Dr. Carolin Auer 12
The 100,000 genomes project
The 100,000 genomes project Tim Hubbard @timjph Genomics England King s College London, King s Health Partners Wellcome Trust Sanger Institute ClinGen / Decipher Washington DC, 26 th May 2015 The 100,000
Information for patients and the public and patient information about DNA / Biobanking across Europe
Information for patients and the public and patient information about DNA / Biobanking across Europe BIOBANKING / DNA BANKING SUMMARY: A biobank is a store of human biological material, used for the purposes
A leader in the development and application of information technology to prevent and treat disease.
A leader in the development and application of information technology to prevent and treat disease. About MOLECULAR HEALTH Molecular Health was founded in 2004 with the vision of changing healthcare. Today
Directorate Medical Operations Patients and Information Nursing Policy Commissioning Development
100,000 Genome Project NHS Genomic Medicine Centre Selection Prospectus July 2014 NHS England INFORMATION READER BOX Directorate Medical Operations Patients and Information Nursing Policy Commissioning
ITT Advanced Medical Technologies - A Programmer's Overview
ITT Advanced Medical Technologies (Ileri Tip Teknolojileri) ITT Advanced Medical Technologies (Ileri Tip Teknolojileri) is a biotechnology company (SME) established in Turkey. Its activity area is research,
Attacking the Biobank Bottleneck
Attacking the Biobank Bottleneck Professor Jan-Eric Litton BBMRI-ERIC BBMRI-ERIC Big Data meets research biobanking Big data is high-volume, high-velocity and highvariety information assets that demand
Vision for the Cohort and the Precision Medicine Initiative Francis S. Collins, M.D., Ph.D. Director, National Institutes of Health Precision
Vision for the Cohort and the Precision Medicine Initiative Francis S. Collins, M.D., Ph.D. Director, National Institutes of Health Precision Medicine Initiative: Building a Large U.S. Research Cohort
Clinical Research Infrastructure at the European level: the ECRIN model. Christine Kubiak ECRIN Coordination Inserm- DRCT
Clinical Research Infrastructure at the European level: the RIN model Christine Kubiak RIN Coordination Inserm- DRCT Finland FinnCRIN Ireland ICRIN UK UKCRN France Inserm Denmark DCRIN Germany KKS Switzerland
Innovation Platform: Sudden Cardiac Death
Innovation Platform: Sudden Cardiac Death Prof. dr. Bart Loeys CRC Antwerp General Assembly VzW Board of Directors Strategic Advisory Board Staff: 1 executive director 1 ICT manager 1 financial administration
Procedure for Requesting Biological Samples and Data from the Accelerated Cure Project MS Repository
Procedure for Requesting Biological Samples and Data from the Accelerated Cure Project MS Repository March 2009 The Accelerated Cure Project Blood, Tissue and Data Bank solicits proposals requesting biological
Opportunities for advancing biomarkers for patient stratification and early diagnosis in liver disease
Opportunities for advancing biomarkers for patient stratification and early diagnosis in liver disease 80 Liver Disease and Obesity Liver disease biomarkers: Percent of adult population (United States)
Biobank Alliance. H.-Erich Wichmann. English version. Helmholtz Zentrum München LMU München
m 4 Biobank Alliance H.-Erich Wichmann English version Helmholtz Zentrum München LMU München Nationale Biobank Initiative Kickoff-Meeting 8. April 2011 TMF Berlin m 4 personalized medicine and target-orientated
Pharmacology skills for drug discovery. Why is pharmacology important?
skills for drug discovery Why is pharmacology important?, the science underlying the interaction between chemicals and living systems, emerged as a distinct discipline allied to medicine in the mid-19th
Digital Health: Catapulting Personalised Medicine Forward STRATIFIED MEDICINE
Digital Health: Catapulting Personalised Medicine Forward STRATIFIED MEDICINE CRUK Stratified Medicine Initiative Somatic mutation testing for prediction of treatment response in patients with solid tumours:
ACRONIM : InNerMeD-I-Network. STARTING DATE: 2013-04-01 DURATION (in months): 30. PRIORITY AREA: Actions under the second objective 'Promote health'
IInherriitted NeuRoMettabolliic Diiseases IINFORMATIION NETWORK ACRONIM : InNerMeD-I-Network STARTING DATE: 2013-04-01 DURATION (in months): 30 PRIORITY AREA: Actions under the second objective 'Promote
STTR PROGRAMMATIC INVESTMENT GRANT APPLICATION
2016 STTR PROGRAMMATIC INVESTMENT GRANT APPLICATION Application Deadline: November 16, 2015 November 30, 2015 BLADDER BRAIN BREAST COLORECTAL HEAD & NECK LUNG OVARY PANCREAS PROSTATE SARCOMA APPLICATION
The Blood Donor BIOBANK
The Blood Donor BIOBANK the first successful combination of blood donation and biobanking for medical research 1 1 Zoglmeier et al., TRANSFUSION 2011, 51(5): 1121-1122 Dr. Franz Weinauer SWISSTRANSFUSION
Personalised Healthcare Frequently Asked Questions
Personalised Healthcare Frequently Asked Questions Foreword In one sense, personalised healthcare is nothing new. It is what doctors have aimed to provide for their patients through the exercise of their
Data in biobanking An emerging new era for data management
3. Main Topic DATA (Sessions C1-5) Data in biobanking An emerging new era for data management Medical University of Graz 21 / 43 C1 - Medical imaging and biobanking (radiology and digital pathology) Jan-Eric
BIOSCIENCES COURSE TITLE AWARD
COURSE TITLE AWARD BIOSCIENCES As a Biosciences undergraduate student at the University of Westminster, you will benefit from some of the best teaching and facilities available. Our courses combine lecture,
Consultation Response Medical profiling and online medicine: the ethics of 'personalised' healthcare in a consumer age Nuffield Council on Bioethics
Consultation Response Medical profiling and online medicine: the ethics of 'personalised' healthcare in a consumer age Nuffield Council on Bioethics Response by the Genetic Interest Group Question 1: Health
Personalized medicine in China s healthcare system
Personalized medicine in China s healthcare system Jingmin Kan, Sam Linsen Netherlands office for Science and Technology, Guangzhou and Shanghai, China Content PERSONALIZED MEDICINE 2 FOCUS AT THE INDIVIDUAL
Proposal to Establish the Crohn s and Colitis Center at the University of Miami Miller School of Medicine
Proposal to Establish the Crohn s and Colitis Center at the University of Miami Miller School of Medicine Contents Mission... 1 Background... 2 Services and Programs... 2 Clinical Care... 2 IBD Specialists...
Doktorate an Medizinischen Universitäten:
Doktorate an Medizinischen Universitäten: gewonnene oder verlorene Zeit? Stefan Boehm Abteilung für Neurophysiologie und pharmakologie Zentrum für Physiologie und Pharmakologie Curriculumdirektor für die
Blood Biobanking Chances and Risks. The Bavarian Red Cross Blood Donor Biobank
Blood Biobanking Chances and Risks The Bavarian Red Cross Blood Donor Biobank EORTC-NCI-ASCO Meeting - November 2007 Outline Types of biobanking Why blood biobanking? Why blood banks? Why the Bavarian
Clinical Research Infrastructure
Clinical Research Infrastructure Enhancing UK s Clinical Research Capabilities & Technologies At least 150m to establish /develop cutting-edge technological infrastructure, UK wide. to bring into practice
Translational research facilitating experimental medicine in dementia in the UK
Translational research facilitating experimental medicine in dementia in the UK Simon Lovestone Director Biomedical Research Unit for dementia at Maudsley and King s Route Map for Dementia Research June
Big Data in Biobanking towards targeted medicine
Big Data in Biobanking towards targeted medicine Ronald Stolk Professor Clinical Epidemiology, UMCG Board member Parelsnoer Institute Chief Scientific Officer LifeLines What is a biobank? Systematic collection
SAP Healthcare Analytics Solutions Provide physicians and researchers access to patient data from various systems in realtime
SAP Healthcare Analytics Solutions Provide physicians and researchers access to patient data from various systems in realtime Stephan Schindewolf, SAP SE, July 13, 2015 Facts per Decision Need Decision
Guide for Writing a Short Proposal
Guide for Writing a Short Proposal Life Sciences PRECISION MEDICINE Call 2016 November 2015 Vienna Science and Technology Fund (WWTF) Schlickgasse 3/12 1090 Vienna, Austria T: +43 (0) 1 4023143-12 (Cornelia
CENTRAL MANCHESTER UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
CENTRAL MANCHESTER UNIVERSITY HOSPITALS NHS FOUNDATION TRUST Agenda Item 9.3 Report of: Paper prepared by: Robert Pearson Medical Director, CMFT Lisa Miles Senior Project Manager, Research & Innovation
Arthritis Research UK Epidemiology Unit
Arthritis Research UK Epidemiology Unit Qualitative research proposal to explore factors influencing acceptable risk thresholds used to recommend particular treatment options for rheumatoid arthritis.
NEW HYBRID IMAGING TECHNOLOGY MAY HAVE BIG POTENTIAL FOR IMPROVING DIAGNOSIS OF PROSTATE CANCER
Media Release April 7, 2009 For Immediate Release NEW HYBRID IMAGING TECHNOLOGY MAY HAVE BIG POTENTIAL FOR IMPROVING DIAGNOSIS OF PROSTATE CANCER London, Ontario Improved hybrid imaging techniques developed
The NeurOmics team at a recent project meeting
Introduction Welcome to the NeurOmics project newsletter. This is the second edition and comes after the project has been underway for just over a year. This means that whilst we still have lots of work
MediSapiens Ltd. Bio-IT solutions for improving cancer patient care. Because data is not knowledge. 19th of March 2015
19th of March 2015 MediSapiens Ltd Because data is not knowledge Bio-IT solutions for improving cancer patient care Sami Kilpinen, Ph.D Co-founder, CEO MediSapiens Ltd Copyright 2015 MediSapiens Ltd. All
From metabiobanks to translational research platforms: Integrating Big Data through CRIP Tools
From metabiobanks to translational research platforms: Integrating Big Data through CRIP Tools 4 th Munich Biomarker Conference, November 26, 2014 christina.schroeder@izi-bb.fraunhofer.de Access to goods
Genomic medicine in Australia. Professor Warwick Anderson Chief Executive Officer National Health and Medical Research Council
Genomic medicine in Australia Professor Warwick Anderson Chief Executive Officer National Health and Medical Research Council This presentation 1. NHMRC s role funding research and translation 2. Genetic/genomic
Telematikplattform für Medizinische Forschungsnetze (TMF) e.v. Berlin / GERMANY
TMF A Common Platform for Medical Research Networks in Germany Improving the Organisation and Infrastructure of Medical Research in Cooperative Structures Welcome! HealthGrid 2008 Conference Chicago, 02-06-2008
Degree Level Expectations, Learning Outcomes, Indicators of Achievement and the Program Requirements that Support the Learning Outcomes
Department/Academic Unit: Pathology and Molecular Medicine Degree Program: PhD Degree Level Expectations, Learning Outcomes, Indicators of Achievement and the Program Requirements that Support the Learning
National Framework for Excellence in
National Framework for Excellence in Lung Cancer Screening and Continuum of Care declaration of purpose Rights and Expectations THE RIGHTS OF THE PEOPLE Lung cancer kills more Americans than the next four
Dr Alexander Henzing
Horizon 2020 Health, Demographic Change & Wellbeing EU funding, research and collaboration opportunities for 2016/17 Innovate UK funding opportunities in omics, bridging health and life sciences Dr Alexander
NEW ALLIANCE FOR EUROPEAN EXCELLENCE AND COMPETITIVENESS IN LIFE SCIENCES
PRESS RELEASE NEW ALLIANCE FOR EUROPEAN EXCELLENCE AND COMPETITIVENESS IN LIFE SCIENCES European research centres in life sciences gather to foster excellence in research, share knowledge, and influence
Curriculum for the Doctor of Philosophy programme Psychology at the Faculty of Psychology and Sport Science of the University of Innsbruck
The English version of the curriculum for the Doctor of Philosophy programme Psychology is not legally binding and is for informational purposes only. The legal basis is regulated in the curriculum published
Revision of the Directive 98/79/EC on In Vitro Diagnostic Medical Devices. Response from Cancer Research UK to the Commission August 2010
Revision of the Directive 98/79/EC on In Vitro Diagnostic Medical Devices Response from Cancer Research UK to the Commission August 2010 1. Cancer Research UK (CR-UK) 1 is leading the world in finding
Breast cancer research and a changing treatment pathway
Breast cancer research and a changing treatment pathway Stuart McIntosh Clinical Senior Lecturer in Surgical Oncology, QUB Consultant Breast Surgeon, BCH What is the breast surgeon s role in 2016? Surgery
Genetic Alliance BioBank: A Virtual Tour of Registry Solutions to Accelerate Research February 22, 2010
Genetic Alliance BioBank: A Virtual Tour of Registry Solutions to Accelerate Research February 22, 2010 Liz Horn Genetic Alliance Posted in the Resource Repository at: http://www.resourcerepository.org/documents/1872/geneticalliancebiobank:avirtualto
Il ruolo dell Advisory Group for «Health, Wellbeing and Demographic Change» in Horizon 2020
Il ruolo dell Advisory Group for «Health, Wellbeing and Demographic Change» in Horizon 2020 Lucia Monaco Horizon 2020 Advisory Group, Societal Challenges 1: Health, Demographic Change and Wellbeing Seminario:
Future from the very beginning
Sandra Hallscheidt School of Business & Economics International Office Future from the very beginning Internationalization at the School of Business & Economics 2 History Titania Palast, Dec. 4, 1948 3
How To Become A Biobanker
IV ESBB Annual Meetin Leipzig, October, 201 Manuel M Morente Spanish National Cancer Research Centre CNIO Spanish National Biobank Network Biobanker Where biobankers comes from We need to prepare a new
Contents. Page 1 of 21
Programme-specific Section of the Curriculum for the MSc Programme in Biochemistry at the Faculty of Science, University of Copenhagen 2009 (Rev. 2015) Contents... 1 1 Title, affiliation and language...
Bachelor of Science in Applied Bioengineering
Bachelor of Science in Applied Bioengineering Applied bioengineering employs scientific and engineering principles to process biological materials from biological agents for provision of goods and related
Ethical and Public Health Implications of Genomic and Personalised Medicine. Dr Ingrid Slade
Ethical and Public Health Implications of Genomic and Personalised Medicine Dr Ingrid Slade Ethical and Public Health Implications of Genomic and Personalised Medicine What is personalised medicine and
Newborn Screening Issues
Newborn Screening Issues - The Public Health Aspect - Dr. Helmut Brand Msc, MFPHM Institute of Public Health NRW, Bielefeld Public Health Genetics is like Mr Tur Tur, the phantom giant: the further you
How To Understand The Relationship Between Genetics And Environment
Different Pathomechanisms for Asthma and Allergies (NEJM 363:121ff) Genetics of Complex Diseases Unraveled by Combining GWAS and Metabolomics (Nature Genetics 42:137. PLoS Genetics 4:1) Disease Management
Roche Position on Human Stem Cells
Roche Position on Human Stem Cells Background Stem cells and treating diseases. Stem cells and their applications offer an enormous potential for the treatment and even the cure of diseases, along with
Medical Informatics I
Medical Informatics I Zlatko Trajanoski Alexander Sturn Institute for Genomics and Bioinformatics Graz University of Technology http://genome.tugraz.at zlatko.trajanoski@tugraz.at Medical Informatics I
4 TH BERLIN-BRANDENBURG TECHNOLOGY FORUM
4 TH BERLIN-BRANDENBURG TECHNOLOGY FORUM June 8 th, 2012 Charité Universitätsmedizin Berlin 4 th Berlin-Brandenburg Technology Forum Facing the economical and medical challenges, new biomarkers and innovative
4.11 Healthcare Technology Co-operatives Version 4 (July 2015)
HEALTHCARE TECHNOLOGY CO-OPERATIVES Introduction The vision of the National Institute for Health Research (NIHR) is to improve the health and wealth of the nation through research. This document sets out
ADVANCING POPULATION HEALTH: NEW MODELS AND THE ROLE OF RESEARCH
22 nd Annual Health Care Systems Research Network (HCSRN) Conference (formerly HMO Research Network Conference) ADVANCING POPULATION HEALTH: NEW MODELS AND THE ROLE OF RESEARCH Hosted by: Marshfield Clinic
FACULTY OF MEDICAL SCIENCE
Doctor of Philosophy Program in Microbiology FACULTY OF MEDICAL SCIENCE Naresuan University 171 Doctor of Philosophy Program in Microbiology The time is critical now for graduate education and research
Vad är bioinformatik och varför behöver vi det i vården? a bioinformatician's perspectives
Vad är bioinformatik och varför behöver vi det i vården? a bioinformatician's perspectives Dirk.Repsilber@oru.se 2015-05-21 Functional Bioinformatics, Örebro University Vad är bioinformatik och varför
Career Opportunities within the French Alliance for Life and Health Sciences
1 Career Opportunities within the French Alliance for Life and Health Sciences Mireille Guyader, PhD Director, Inserm-USA Office INSERM KEY FIGURES (Year 2013) Budget: 970 M (~ $1.2 Billion) Human resources:
Regulatory Issues in Genetic Testing and Targeted Drug Development
Regulatory Issues in Genetic Testing and Targeted Drug Development Janet Woodcock, M.D. Deputy Commissioner for Operations Food and Drug Administration October 12, 2006 Genetic and Genomic Tests are Types
FACULTY OF MEDICAL SCIENCE
Doctor of Philosophy in Biochemistry FACULTY OF MEDICAL SCIENCE Naresuan University 73 Doctor of Philosophy in Biochemistry The Biochemistry Department at Naresuan University is a leader in lower northern
Healthcare Coalition on Data Protection
Healthcare Coalition on Data Protection Recommendations and joint statement supporting citizens interests in the benefits of data driven healthcare in a secure environment Representing leading actors in
Data Integration and Knowledge Management within Oncotyrol A. Dander, R. Gallasch, S. Pabinger, H. Fiegl, Z. Trajanoski
Data Integration and Knowledge Management within Oncotyrol A. Dander, R. Gallasch, S. Pabinger, H. Fiegl, Z. Trajanoski Oncotyrol, Center for Personalized Cancer Medicine, Innsbruck, Austria Biocenter,
Research and Innovation Strategy: delivering a flexible workforce receptive to research and innovation
Research and Innovation Strategy: delivering a flexible workforce receptive to research and innovation Contents List of Abbreviations 3 Executive Summary 4 Introduction 5 Aims of the Strategy 8 Objectives
European registered Clinical Laboratory Geneticist (ErCLG) Core curriculum
(February 2015; updated from paper issued by the European Society of Human Genetics Ad hoc committee for the accreditation of clinical laboratory geneticists, published in February 2012) Speciality Profile
Institut für Klinische Chemie und Laboratoriumsmedizin. In vitro Diagnostics in the Health Care System of Germany. Karl J. Lackner
In vitro Diagnostics in the Health Care System of Germany Karl J. Lackner Laboratory Medicine in Germany Major goal is to analyze body fluids (e.g. blood, urine, CSF) to support clinical diagnostics and
LifeLines Cohort Study. Salome Scholtens, Manager Research Office
LifeLines Cohort Study Salome Scholtens, Manager Research Office What is LifeLines? Biobank» LifeLines Cohort & Biorepository 165,000 participants at least 30 years follow-up Three generation design Northern
TO THE JOINT TRANSNATIONAL CALL 2015 FOR EPIGENOMICS OF COMPLEX DISEASES
CALL TEXT TO THE JOINT TRANSNATIONAL CALL 2015 FOR EPIGENOMICS OF COMPLEX DISEASES Submission deadline of proposals: 30 th of January 2015 at 01 p.m. CET (Paris, Berlin local time) Link to Call for Proposals
<Insert Picture Here> The Evolution Of Clinical Data Warehousing
The Evolution Of Clinical Data Warehousing Srinivas Karri Principal Consultant Agenda Value of Clinical Data Clinical Data warehousing & The Big Data Challenge
Ask Us About Clinical Trials
Ask Us About Clinical Trials Clinical Trials and You. Our specialists and researchers are at the forefront of their fields and are leading the way in developing new therapies and procedures for diagnosing
STW Open Technology Programme. H2020 Future & Emerging Technology. and. GRANTS WEEK 2015 October 9 th
STW Open Technology Programme and H2020 Future & Emerging Technology GRANTS WEEK 2015 October 9 th 9/12/2010 INDIVIDUAL FUNDING OPPORTUNITIES IN EUROPE 1 SUPPORT FOR RESEARCH FUNDING ACQUISITION AT THE
Fiscal Year 2013 (FY13) Prostate Cancer Research Program (PCRP) Reference Table of Award Mechanisms and Submission Requirements
Fiscal Year 2013 (FY13) Prostate Cancer Research Program (PCRP) Reference Table of Award Mechanisms and Submission Requirements PCRP AWARD MECHANISMS WITH EMPHASIS ON RESOURCES Clinical Consortium Award
Medical research charities and the NHS - how can we get the best for patients?
Medical research charities and the NHS - how can we get the best for patients? Dr Liz Philpots, head of research 2015 Annual NHS R&D forum 5-6 May 2015 overview getting the best for patients scene setting
Welcome Address by the. State Secretary at the Federal Ministry of Education and Research. Dr Georg Schütte
Welcome Address by the State Secretary at the Federal Ministry of Education and Research Dr Georg Schütte at the "Systems Biology and Systems Medicine" session of the World Health Summit at the Federal
University of Washington Institute for Public Health Genetics
University of Washington Institute for Public Health Genetics Table of Contents for MPH in Public Health Genetics Guidelines Part 2 Updated January 28, 2014 Part 1 Program Goal and Course of Study Part
Modelling the integration of biobanks into healthcare systems International Biobanking Summit II: Future Directions Graz, 17 September 2013
Modelling the integration of biobanks into healthcare systems International Biobanking Summit II: Future Directions Graz, 17 September 2013 Anthony J Brookes University of Leicester Biobank: A comprehensive
Birmingham Professional Forum
Birmingham Professional Forum Lee Sanders, Registrar and Secretary 2 April 2015 Agenda Introduction - Lee Sanders An introduction to Chris Granger, Director of Finance Higher Education Review - Professor
LIFE SCIENCES QUEENSLAND LIMITED (LSQ) Mario Pennisi CEO. @LSQld
LIFE SCIENCES QUEENSLAND LIMITED (LSQ) Mario Pennisi CEO @LSQld LEADING DESTINATION FOR CLINICAL RESEARCH INVESTORS IN QLD INCLUDE: LIFE SCIENCES IN QLD ~300 companies in life sciences ~$5B invested by
Nanomedicine in Horizon 2020
Nanomedicine in Horizon 2020 Heico FRIMA Programme Officer European Commission Directorate-General for Research & Directorate D: Key Enabling Technologies heico.frima@ec.europa.eu ETPN Annual Event 2014
The National Institute of Genomic Medicine (INMEGEN) was
Genome is...... the complete set of genetic information contained within all of the chromosomes of an organism. It defines the particular phenotype of an individual. What is Genomics? The study of the
Focus Biobank Inflammatory Bowel Disease
Focus Biobank Inflammatory Bowel Disease University Hospitals Leuven KU Leuven Isabelle Cleynen, PhD Inflammatory Bowel Disease Crohn s disease (CD) Entire GI tract Transmural Fistulas and/or strictures
Advanced Nursing Research in Critical Care
12 th Congress of the World Federation of Societies of Intensive and Critical Care Medicine Advanced Nursing Research in Critical Care Yeonsoo Jang RN, PhD. Assistant Professor Yonsei University College
Clinical Cancer Genomes. on behalf of the GA4GH Clinical Working Group
Clinical Cancer Genomes Mark Lawler (Queen s University Belfast and GA4GH Clinical Working Group) on behalf of the GA4GH Clinical Working Group Disclosure Statement Disclosure Statement I have nothing
#Aim2Innovate. Share session insights and questions socially. Genomics, Precision Medicine and the EHR 6/17/2015
Genomics, Precision Medicine and the EHR Making Genomics part of everyday practice Andrew Ury, M.D. CEO and founder, ActX, Inc. June 17, 2015 DISCLAIMER: The views and opinions expressed in this presentation
TABLE OF CONTENTS. Introduction...1. Chapter1 AdvancesinTreatment...2. Chapter2 MedicinesinDevelopment...11. Chapter3 ValueandSpending...
CANCER TABLE OF CONTENTS Introduction...1 Chapter1 AdvancesinTreatment...2 Chapter2 MedicinesinDevelopment......11 Chapter3 ValueandSpending......15 Chapter4 Conclusion...22 INTRODUCTION Researchers and
Biotechnology and Life Science Marketing Services Mailing List and Data Card Order Form
C H I Cambridge Healthtech Institute s Biotechnology and Life Science Marketing Services Mailing List and Data Card Order Form Over 800,000 names segmented by scientific interest Featuring U.S and International
Building a Collaborative Informatics Platform for Translational Research: Prof. Yike Guo Department of Computing Imperial College London
Building a Collaborative Informatics Platform for Translational Research: An IMI Project Experience Prof. Yike Guo Department of Computing Imperial College London Living in the Era of BIG Big Data : Massive
Genetic testing. The difference diagnostics can make. The British In Vitro Diagnostics Association
6 Genetic testing The difference diagnostics can make The British In Vitro Diagnostics Association Genetic INTRODUCTION testing The Department of Health published Our Inheritance, Our Future - Realising
EBiSC the first European bank for induced pluripotent stem cells
Press Release EBiSC the first European bank for induced pluripotent stem cells Pharmaceutical companies who are members of the European Federation of Pharmaceutical Industries and Associations (EFPIA)
Big Data for Population Health and Personalised Medicine through EMR Linkages
Big Data for Population Health and Personalised Medicine through EMR Linkages Zheng-Ming CHEN Professor of Epidemiology Nuffield Dept. of Population Health, University of Oxford Big Data for Health Policy
Technology funding opportunities at the National Cancer Institute
Technology funding opportunities at the National Cancer Institute Through the Cancer Diagnosis Program http://cancerdiagnosis.nci.nih.gov/index.html Avraham Rasooly Ph.D. National Cancer Institute, Cancer
TRACKS GENETIC EPIDEMIOLOGY
Dr. Priya Duggal, Director In the post-genomic era where larger amounts of genetic data are now readily available, it has become increasingly important to design studies and use analytical techniques that
BIO-PARTNERING EUROPE EVENT SPEECH PAOLA TESTORI COGGI DIRECTOR GENERAL FOR HEALTH AND CONSUMERS EUROPEAN COMMISSION
EUROPABIO BIO-PARTNERING EUROPE EVENT TUESDAY 9 OCTOBER 2012 9.10 9.20 HRS SPEECH BY PAOLA TESTORI COGGI DIRECTOR GENERAL FOR HEALTH AND CONSUMERS EUROPEAN COMMISSION I am pleased to have the opportunity
Biobanking Pluripotent Stem Cell Lines: UK and EU regulations Glyn Stacey, UK Stem Cell Bank, NIBSC
Biobanking Pluripotent Stem Cell Lines: UK and EU regulations Glyn Stacey, UK Stem Cell Bank, NIBSC ISCT Conference, New Zealand, April 2013 April 1 st 2013 NIBSC will become part of the Medicines and
8 th Senftenberg Innovation Forum on Multiparametric Analysis. May 7 8 2014 Senftenberg Germany
8 th Senftenberg Innovation Forum on Multiparametric Analysis AUTOIMMUNE Diagnostics May 7 8 2014 Senftenberg Germany In cooperation with: Media Partner: Recent developments of multiparametric technologies
World Class Personalized Cancer Medicine
World Class Personalized Cancer Medicine The Princess Margaret Cancer Centre Strategy 2013 2018 2015 Edition Contents 4 The Princess Margaret Cancer Centre 6 Accountability 7 Our Core Activities and Resources